March 1996 - Volume 19 - Issue 2 - Contributor Index

Alphabetical Search
E
I
Q
W
X
Y
Z

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Author:
Bot, Frederik

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Author:
Bucci, E.
Author:
Citterio, G.
Author:
Cizza, Giovanni

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Figlin, Robert
Author:
Foppoli, M.
Author:
Forni, Guido
Author:
Fragasso, G.

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Author:
Guerrieri, R.
Author:
Hu, H. Z.
Author:
Janik, John E.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Jonker, M.
Author:
Kaboo, Randhir
Author:
Lerda, Walter
Author:
Longo, Dan L.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Lucca, G. Di
Author:
Matteucci, P.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Pang, Shen
Author:
Pierce, William
Author:
Polastri, D.
Author:
Rigaut, K.
Author:
Rogers, Joy D.
Author:
Rossetti, E.
Author:
Rugarli, C.
Author:
Scaglietti, U.
Author:
Scharff, J.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Shiloach, J.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Author:
Slingerland, W.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Tresoldi, M.
Author:
Tso, Cho-Lea
Author:
Urba, Walter J.

Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer

Curti, Brendan D.; Urba, Walter J.; Longo, Dan L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):142-148, March 1996.

Author:
Valente, Guido

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Low-Dose rIL-2-Induced Remission of Disseminated CD30+ Anaplastic Large-Cell Lymphoma Through Reinforcement of Presumed T-Cell-Mediated Tumor Cell Killing, Complicated by Unilateral Drowning of Lymphoma-Infiltrated Lung

Beun, Gideon D. M.; Vlasveld, Lodewijk T.; Bot, Frederik; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(2):162-167, March 1996.

Show: